Market Research Logo

Global Dry Eye Syndrome Drugs Market 2017-2021

Global Dry Eye Syndrome Drugs Market 2017-2021

About Dry Eye Syndrome Drugs

Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.

Technavio’s analysts forecast the global dry eye syndrome drugs market to grow at a CAGR of 7.59% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global dry eye syndrome drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Dry Eye Syndrome Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Allergan
  • Novartis
  • Otsuka Holdings
  • Santen Pharmaceutical
Other prominent vendors
  • Aerie Pharmaceutical
  • Akorn
  • Bausch & Lomb
  • Johnson & Johnson
  • Merck
  • MIMETOGEN
  • ReGenTree
  • Sun Pharmaceutical
  • Teva Pharmaceutical
Market driver
  • Untapped potential in developing countries
  • For a full, detailed list, view our report
Market challenge
  • Lack of ophthalmology experts
  • For a full, detailed list, view our report
Market trend
  • Initiatives and programs for supporting patients with ophthalmic disorders
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Dry Eye Syndrome Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global dry eye syndrome drugs market: Allergan, Novartis, Otsuka Holdings, and Santen Pharmaceutical.

Other Prominent Vendors in the market are: Aerie Pharmaceutical, Akorn, Bausch & Lomb, Johnson & Johnson, Merck, MIMETOGEN, ReGenTree, Sun Pharmaceutical, and Teva Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is Initiatives and programs for supporting patients with ophthalmic disorders. Public awareness about problems related to visual impairment has increased in the last decade because of the increase in the number of government initiatives undertaken by various organizations.”

According to the report, one driver in the market is untapped potential in developing countries. Countries such as India, China, and Brazil are some of the most attractive countries for pharmaceutical companies globally. Several factors are responsible for the high growth of the healthcare sector in developing countries. Vast population, growing geriatric population, and lifestyle disorders such as obesity and diabetes that lead to dry eye syndrome are factors expected to drive the market in developing countries.

Further, the report states that one challenge in the market is lack of ophthalmology experts. The lack of trained ophthalmologists who have expertise in treating eye disorders such as dry eyes is one of the key challenges in the market. Although the number of people diagnosed with or prone to eyesight disorders has been on the rise, there are insufficient trained and experienced eye care professionals (ophthalmologists, optometrists, ophthalmic assistants, and ophthalmic nurses) to treat eye disorders. For instance, in Europe, there is just one ophthalmologist for every 8,000 individuals.

Companies Mentioned

Allergan, Novartis, Otsuka Holdings, Santen Pharmaceutical, Aerie Pharmaceutical, Akorn, Bausch & Lomb, Johnson & Johnson, Merck, MIMETOGEN, ReGenTree, Sun Pharmaceutical, and Teva Pharmaceutical.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table Market share of ophthalmic drugs market 2016
      • Table Causes of dry eyes
      • Table Symptoms, diagnosis, and treatment of dry eyes
  • Market landscape
    • Table Dry eye syndrome drugs market: Snapshot
    • Table Global dry eye syndrome drugs market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline molecules in Phase III by vendors
    • Table Key clinical trials
  • Market segmentation by product
    • Table Global dry eye syndrome drugs market by product 2016-2021 (% share)
    • OTC drugs
      • Table Global dry eye syndrome drugs market by OTC drugs 2016-2021 ($ millions)
      • Table Qualities of OTC drugs present in the market
      • Table OTC drugs based on inclusion of preservatives
    • Prescription drugs
      • Table Global dry eye syndrome drugs market by prescription drugs 2016-2021 ($ millions)
  • Regional landscape
    • Table Regional landscape
    • Regional comparison
      • Table Regional comparison
    • Dry eye syndrome drugs market in Americas
      • Table Dry eye syndrome drugs market in Americas 2016-2021 ($ millions)
      • Table Dry eye syndrome drugs market in Americas - Year over year growth
    • Dry eye syndrome drugs market in EMEA
      • Table Dry eye syndrome drugs market in EMEA 2016-2021 ($ millions)
      • Table Dry eye syndrome drugs market in EMEA - Year over year growth
    • Dry eye syndrome drugs market in APAC
      • Table Dry eye syndrome drugs market in APAC 2016-2021 ($ millions)
      • Table Dry eye syndrome drugs market in APAC - Year over year growth
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table World population by age group: 2015-2050
      • Table Percentage of population aged 60 and above by region 2015-2050
      • Table Risk factors for developing dry eye syndrome in older population
      • Table Demographic and economic snapshot of India and China
      • Table Factors causing autoimmune disorders
    • Market challenges
      • Table Top concerns of health insurance in US
  • Market trends
    • Initiatives and programs for supporting patients with ophthalmic disorders
    • Advancement in diagnostic techniques for dry eye syndrome
  • Vendor landscape
    • Table Competitive structure analysis of global dry eye syndrome drugs market 2016
    • Table Vendor landscape for global dry eye syndrome drugs market 2016-2021
  • Key vendor analysis
    • Allergan
      • Table Allergan: Key highlights
      • Table Allergan: Strength assessment
      • Table Allergan: Strategy assessment
      • Table Allergan: Opportunity assessment
    • Otsuka Holdings
      • Table Otsuka Holdings: Key highlights
      • Table Otsuka Holdings: Strength assessment
      • Table Otsuka Holdings: Strategy assessment
      • Table Otsuka Holdings: Opportunity assessment
    • Novartis
      • Table Novartis: Key highlights
      • Table Novartis: Strength assessment
      • Table Novartis: Strategy assessment
      • Table Novartis: Opportunity assessment
    • Santen Pharmaceutical
      • Table Santen Pharmaceutical: Key highlights
      • Table Santen Pharmaceutical: Strength assessment
      • Table Santen Pharmaceutical: Strategy assessment
      • Table Santen Pharmaceutical: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report